CYPH
Cypherpunk Technologies Inc.NASDAQFINANCIAL SERVICESASSET MANAGEMENT
Key Statistics
Market Cap
$95.07M
P/E Ratio
13.90
EPS
$0.07
Beta
-0.22
52W High
$3.70
52W Low
$0.23
50-Day MA
$0.76
200-Day MA
$0.77
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-36.69M |
| Operating Margin | 0.00% |
| Return on Equity | 5.11% |
| Return on Assets | -21.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.83 |
| Price-to-Book | 0.62 |
| Price-to-Sales (TTM) | 160.10 |
| EV/Revenue | - |
| EV/EBITDA | 8.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $97.68M |
| Float | $72.63M |
| % Insiders | 8.01% |
| % Institutions | 18.00% |
Historical Volatility
HV 10-Day
101.41%
HV 20-Day
119.35%
HV 30-Day
124.29%
HV 60-Day
139.12%
HV Rank
—
Volatility is currently contracting
More FINANCIAL SERVICES Stocks
Data last updated: 5/2/2026